Exploring the Anticancer Potential of Synthetic β-Carboline Derivatives: A Comprehensive Systematic Review

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Synthesis

Background:

• Cancer poses a significant global health challenge, driving the search for novel therapeutic agents.
• Synthetic β-carboline derivatives have demonstrated promising anticancer properties.
• This review focuses on β-carboline derivatives synthesized over the past two decades.

Purpose of the Study:

• To systematically review the anticancer potential of synthetic β-carboline derivatives.
• To analyze their chemistry, synthesis, pharmacology, and mechanisms of action.
• To identify structure-activity relationships for enhanced anticancer efficacy.

Main Methods:

• A comprehensive literature search was performed across major scientific databases (PubMed, Embase, Web of Science, Scopus).
• 270 relevant studies were selected based on predefined inclusion criteria.
• Data extraction focused on anticancer activities, structure-activity relationships, and mechanistic insights.

Main Results:

• Synthetic β-carboline derivatives exhibit diverse anticancer mechanisms, including DNA binding and apoptosis induction.
• These compounds showed significant efficacy in both in vitro and in vivo preclinical models.
• Chemical modifications and structural features were identified as key factors for enhanced anticancer activity.

Conclusions:

• β-carboline derivatives target multiple molecular pathways, indicating broad therapeutic potential.
• Structure-activity relationship data suggests avenues for medicinal chemistry optimization.
• In silico approaches and metal complexation offer further scope for therapeutic development.